Trailing-twelve-month figures for context around the print.
Market cap
$386.3B
EPS (TTM)
$15.55
P/E (TTM)
27.4
price ÷ trailing earnings
Revenue growth
+6.5%
TTM vs a year ago
Net margin
3.1%
of revenue kept as profit
52-week range
$235 – $462
now $428.79
Beta
0.63
steadier than the market
Dividend yield
2.10%
trailing twelve months
Estimates and reported figures via Finnhub; crowd odds are UnitedHealth Group forecasts on Probs. Information, not investment advice.